Related Experiment Video
Updated: Jul 22, 2025

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
PKCα Isoform Inhibits Insulin Signaling and Aggravates Neuronal Insulin Resistance
Devanshi Mishra1, Ishitha Reddy1, Chinmoy Sankar Dey2
1Kusuma School of Biological Sciences, Indian Institute of Technology-Delhi, New Delhi, Hauz Khas, -110016, India.
Abstract:
Overexpression of PKCα has been linked to inhibit insulin signaling disrupting IRS-1 and Akt phosphorylations in skeletal muscle. PKCα inhibits IRS-1 and Akt phosphorylations, but not required for insulin-stimulated glucose transport in skeletal muscles. Inhibition of PKCα increased whereas in some studies decreased GLUT-4 levels at the plasma membrane in skeletal muscles and adipocytes. Controversial studies have reported opposite expression pattern of PKCα expression in insulin-resistant skeletal muscles. These findings indicate that the role of PKCα on insulin signaling is controversial and could be tissue specific. Evidently, studies are required to decipher the role of PKCα in regulating insulin signaling and preferably in other cellular systems. Utilizing neuronal cells, like Neuro-2a, SHSY-5Y and insulin-resistant diabetic mice brain tissues; we have demonstrated that PKCα inhibits insulin signaling, through IRS-Akt pathway in PP2A-dependent mechanism by an AS160-independent route involving 14-3-3ζ. Inhibition and silencing of PKCα improves insulin sensitivity by increasing GLUT-4 translocation to the plasma membrane and glucose uptake. PKCα regulates GSK3 isoforms in an opposite manner in insulin-sensitive and in insulin-resistant condition. Higher activity of PKCα aggravates insulin-resistant neuronal diabetic condition through GSK3β but not GSK3α. Our results mechanistically explored the contribution of PKCα in regulating neuronal insulin resistance and diabetes, which opens up new avenues in dealing with metabolic disorders and neurodegenerative disorders.
Insights
Protein kinase C alpha (PKCα) overexpression disrupts insulin signaling in neurons. Inhibiting PKCα enhances insulin sensitivity and glucose uptake, offering new therapeutic targets for metabolic and neurodegenerative disorders.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Cellular Signaling
Background:
- Protein kinase C alpha (PKCα) role in insulin signaling is controversial and tissue-specific.
- Previous studies linked PKCα overexpression to inhibited insulin signaling in skeletal muscle, but its precise role remains unclear.
- The function of PKCα in neuronal insulin resistance and diabetes requires further investigation.
Purpose of the Study:
- To elucidate the role of PKCα in neuronal insulin signaling and insulin resistance.
- To investigate the molecular mechanisms by which PKCα affects insulin sensitivity in neuronal cells.
- To explore the potential of targeting PKCα for treating metabolic and neurodegenerative disorders.
Main Methods:
- Utilized neuronal cell lines (Neuro-2a, SHSY-5Y) and insulin-resistant diabetic mouse brain tissues.
- Investigated the interaction of PKCα with insulin signaling pathway components, including IRS-Akt, PP2A, AS160, 14-3-3ζ, and GSK3 isoforms.
- Assessed the effects of PKCα inhibition and silencing on GLUT-4 translocation, glucose uptake, and insulin sensitivity.
Main Results:
- PKCα was demonstrated to inhibit insulin signaling in neuronal cells via an IRS-Akt pathway, involving PP2A and 14-3-3ζ, independently of AS160.
- Inhibition or silencing of PKCα improved insulin sensitivity, increased GLUT-4 translocation to the plasma membrane, and enhanced glucose uptake.
- PKCα differentially regulated GSK3 isoforms, with higher activity exacerbating insulin resistance in a GSK3β-dependent manner.
Conclusions:
- PKCα plays a significant role in regulating insulin signaling and contributing to neuronal insulin resistance and diabetes.
- Targeting PKCα presents a promising therapeutic strategy for metabolic disorders and neurodegenerative conditions.
- The findings provide mechanistic insights into PKCα's contribution to neuronal dysfunction in diabetes.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
GPCR Desensitization
PI3K/mTOR/AKT Signaling Pathway
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

